Concepedia

J. Carmichael

JC

Statistics

Publications

14

Citations

635

H-Index

12

Active since

1920

Affiliations

University of Manitoba(Current)

University of Winnipeg

Churchill Hospital

J. Carmichael is an author at University of Manitoba specializing in medicine, cancer pharmacology, and pharmacology.

Publications per year

1920–2018

14

Publications

14

Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor   Induction In Vivo

P. A. Philip, Daniel Rea, P. Thavasu et al. · JNCI Journal of the National Cancer Institute · 1993 · 187 citations

, , +15

Can we define tumors that will respond to PARP inhibitors? A phase II correlative study of olaparib in advanced serous ovarian cancer and triple-negative breast cancer.

Karen A. Gelmon, Hal W. Hirte, A. Robidoux et al. · Journal of Clinical Oncology · 2010 · 103 citations

, , +17

The role of glutathione in determining the response of normal and tumour cells to anticancer drugs

C.R. Wolf, Alexander D. Lewis, J. Carmichael et al. · Biochemical Society Transactions · 1987 · 54 citations

, , +12

CONTRIBUTIONS TO THE BIOCHEMISTRY OF IODINE

A. T. Cameron, J. Carmichael · Journal of Biological Chemistry · 1920 · 50 citations · Full text

, , +6

Large variation in use of patient-reported outcome measures: A survey of 188 foot and ankle surgeons

Ruben Zwiers, Hanneke Weel, Wouter H. Mallee et al. · Foot and Ankle Surgery · 2017 · 42 citations

, , +16

1–5 of 14